阿片类药物,微质,以及叶
Lauren Marijke Lankhuijzen1, Thomas Ridler1
1Hatherly Laboratories, Department of Clinical and Biomedical Sciences, University of Exeter Medical School, University of Exeter, Exeter, United Kingdom.
Frontiers in neurology
|January 22, 2024
概括
阿片类药物,特别是迪诺芬和卡帕-阿片类受体,通过调节微细胞活化和减少神经炎症,在治疗叶 (TLE) 中表现有前途. 这项研究表明了管理的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 的研究研究.
背景情况:
- 叶 (TLE) 缺乏足够的治疗选择,需要新的治疗方法.
- 由微质激活驱动的神经炎症会加剧TLE.
- 内源性阿片类药物,如丁诺芬,提供了管理神经元刺激性的潜力.
研究的目的:
- 批判性地审查关于阿片类药物在中调节微质功能和形态学的作用的文献.
- 通过向神经炎症来评估阿片类药物作为TLE的潜在治疗方法.
- 探索阿片类药物介导的神经保护和发作减少.
主要方法:
- 文献综述,重点关注中阿片类药物-小质相互作用.
- 对阿片类受体激活对微质功能影响的分析.
- 检查在阿片类药物介导的微质调节中类似收费4受体的作用.
主要成果:
- 急性阿片类受体激活通过类似于收费的4个受体调节微质激活.
- 阿片类药物调节调节下游细胞因子分泌,影响神经炎症.
- 临床前证据支持阿片类药物抑制发作和增强神经保护的潜力.
结论:
- 阿片类药物可以在中中断炎症循环,保护神经元功能.
- 向阿片类药物 - 微质相互作用为TLE提供了一个新的治疗途径.
- 对微质的阿片类调节的进一步研究对治疗有重大影响.
相关概念视频
Analgesia and Pain Management
625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Opioid Receptors: Overview
847
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
847


